Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy

ClinicalTrials.gov ID: NCT01676116

Public ClinicalTrials.gov record NCT01676116. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 1:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy (DUAL™ III -GLP-1 Switch)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted in Europe, Oceania and the United States of America (USA). The aim of the trial is to investigate the efficacy of insulin degludec/liraglutide in controlling glycaemia in adults with type 2 diabetes inadequately controlled on glucagon-like peptide-1 (GLP-1) receptor agonist and OAD therapy.

Study identification

NCT ID
NCT01676116
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
438 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 29, 2012 (Actual)
Primary completion
Mar 11, 2014 (Actual)
Completion
Mar 11, 2014 (Actual)
Last update posted
Jan 3, 2019

2012 – 2014

United States locations

U.S. sites
85
U.S. states
26
U.S. cities
76
Facility City State ZIP Site status
Novo Nordisk Investigational Site Birmingham Alabama 35216 —
Novo Nordisk Investigational Site Goodyear Arizona 85395 —
Novo Nordisk Investigational Site Mesa Arizona 85206 —
Novo Nordisk Investigational Site Phoenix Arizona 85018 —
Novo Nordisk Investigational Site Concord California 94520 —
Novo Nordisk Investigational Site Encino California 91436 —
Novo Nordisk Investigational Site Fair Oaks California 95628 —
Novo Nordisk Investigational Site Fresno California 93720 —
Novo Nordisk Investigational Site Greenbrae California 94904 —
Novo Nordisk Investigational Site Lancaster California 93534 —
Novo Nordisk Investigational Site Lomita California 90717 —
Novo Nordisk Investigational Site Long Beach California 90806 —
Novo Nordisk Investigational Site Montclair California 91763 —
Novo Nordisk Investigational Site Northridge California 91325 —
Novo Nordisk Investigational Site San Mateo California 94401 —
Novo Nordisk Investigational Site San Ramon California 94583 —
Novo Nordisk Investigational Site Tarzana California 91356-3551 —
Novo Nordisk Investigational Site Van Nuys California 91405 —
Novo Nordisk Investigational Site Colorado Springs Colorado 80910 —
Novo Nordisk Investigational Site Bradenton Florida 34201 —
Novo Nordisk Investigational Site Fort Myers Florida 33912-4343 —
Novo Nordisk Investigational Site Jacksonville Florida 32204 —
Novo Nordisk Investigational Site Jacksonville Florida 32207 —
Novo Nordisk Investigational Site Jacksonville Florida 32216 —
Novo Nordisk Investigational Site Jacksonville Florida 32258 —
Novo Nordisk Investigational Site Miami Florida 33135 —
Novo Nordisk Investigational Site Miami Florida 33136 —
Novo Nordisk Investigational Site Miami Florida 33155 —
Novo Nordisk Investigational Site Miami Florida 33156 —
Novo Nordisk Investigational Site Miami Springs Florida 33166 —
Novo Nordisk Investigational Site Orlando Florida 32806 —
Novo Nordisk Investigational Site Plant City Florida 33563 —
Novo Nordisk Investigational Site Winter Haven Florida 33880 —
Novo Nordisk Investigational Site Atlanta Georgia 30318 —
Novo Nordisk Investigational Site Roswell Georgia 30076 —
Novo Nordisk Investigational Site Honolulu Hawaii 96814 —
Novo Nordisk Investigational Site Arlington Heights Illinois 60004-2315 —
Novo Nordisk Investigational Site Indianapolis Indiana 46254 —
Novo Nordisk Investigational Site Lexington Kentucky 40503 —
Novo Nordisk Investigational Site Rockville Maryland 20852 —
Novo Nordisk Investigational Site Kalamazoo Michigan 49048 —
Novo Nordisk Investigational Site Troy Michigan 48098 —
Novo Nordisk Investigational Site Saint Charles Missouri 63303 —
Novo Nordisk Investigational Site Omaha Nebraska 68124 —
Novo Nordisk Investigational Site Henderson Nevada 89052-2649 —
Novo Nordisk Investigational Site Las Vegas Nevada 89128 —
Novo Nordisk Investigational Site Reno Nevada 89502-0111 —
Novo Nordisk Investigational Site Nashua New Hampshire 03063 —
Novo Nordisk Investigational Site Berlin New Jersey 08009 —
Novo Nordisk Investigational Site Flemington New Jersey 08822-5763 —
Novo Nordisk Investigational Site Hamilton New Jersey 08619 —
Novo Nordisk Investigational Site Lawrenceville New Jersey 08648 —
Novo Nordisk Investigational Site Toms River New Jersey 08753-2975 —
Novo Nordisk Investigational Site Mineola New York 11501 —
Novo Nordisk Investigational Site North Massapequa New York 11758-1802 —
Novo Nordisk Investigational Site West Seneca New York 14224 —
Novo Nordisk Investigational Site Morehead City North Carolina 28557 —
Novo Nordisk Investigational Site Columbus Ohio 43214 —
Novo Nordisk Investigational Site Dayton Ohio 45439 —
Novo Nordisk Investigational Site Altoona Pennsylvania 16602 —
Novo Nordisk Investigational Site Pittsburgh Pennsylvania 15243 —
Novo Nordisk Investigational Site Myrtle Beach South Carolina 29572 —
Novo Nordisk Investigational Site Sumter South Carolina 29150-1900 —
Novo Nordisk Investigational Site Chattanooga Tennessee 37404 —
Novo Nordisk Investigational Site Jellico Tennessee 37762 —
Novo Nordisk Investigational Site Kingsport Tennessee 37660 —
Novo Nordisk Investigational Site Nashville Tennessee 37212 —
Novo Nordisk Investigational Site Tullahoma Tennessee 37388 —
Novo Nordisk Investigational Site Arlington Texas 76014 —
Novo Nordisk Investigational Site Austin Texas 78731 —
Novo Nordisk Investigational Site Dallas Texas 75218 —
Novo Nordisk Investigational Site Dallas Texas 75231 —
Novo Nordisk Investigational Site Fort Worth Texas 76113 —
Novo Nordisk Investigational Site Houston Texas 77074 —
Novo Nordisk Investigational Site Houston Texas 77095 —
Novo Nordisk Investigational Site Plano Texas 75075 —
Novo Nordisk Investigational Site Round Rock Texas 78681 —
Novo Nordisk Investigational Site San Antonio Texas 78215 —
Novo Nordisk Investigational Site San Antonio Texas 78249 —
Novo Nordisk Investigational Site Schertz Texas 78154 —
Novo Nordisk Investigational Site Sugar Land Texas 77478 —
Novo Nordisk Investigational Site Orem Utah 84058 —
Novo Nordisk Investigational Site Salt Lake City Utah 84107 —
Novo Nordisk Investigational Site St. George Utah 84790 —
Novo Nordisk Investigational Site Richmond Virginia 23219 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01676116, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 3, 2019 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01676116 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →